tiprankstipranks
Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC
PremiumPress ReleasesMerus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC
12d ago
MRUS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
MRUS Earnings this Week: How Will it Perform?
14d ago
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
PremiumPress Releases
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100